Positron emitting (18)F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy

Preclinical studies suggest that (18)F-2-deoxy-2-fluoro-D-glucose ((18)F-FDG) kills breast cancer cells without significant marrow toxicity or parenchymal toxicity. Radiation dose calculations estimated from fluorodeoxyglucose positron emission tomography images in women with metastatic disease indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mortimer, Joanne E, Taylor, Marie E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314419/
https://www.ncbi.nlm.nih.gov/pubmed/14580251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314419/
https://www.ncbi.nlm.nih.gov/pubmed/14580251

Ejemplares similares